Dr. Petros Grivas discusses intravesical treatment for patients with nonmuscle invasive, or early-stage, bladder cancer, the importance of participating in clinical trials for bladder cancer, combination therapy options for patients with metastatic or incurable bladder cancer, and the importance of
Video Library
Search the Video Library
Video Language
Filter by Cancer Type:
Displaying Results 1 - 15 of 294
Oncologists discuss emerging data surrounding treatment options for patients with bladder cancer.
Drs. Desai and Abu Rous discuss emerging information and trial data as presented at ASCO 2024.
In this video series from ASCO 2024, Drs. Aakash Desai and Fauwzi Abu Rous discuss trial dates and clinical data as presented at the 2024 ASCO. To watch the complete playlist, click here.
A panel of oncologists come together to discuss hypothetical cases of lung cancer, and how they would go about treating them.
The panel discusses treatment options for a patient diagnosed with EGFR Exon 19 Deletion NSCLC and examines data from the Laura Trial, a patient with a smoking history and diagnosis of small cell lung cancer, and how the Adriatic Study factors into decisions, and a patient with NSCLC adenocarcinoma
El Foro de Terapias Dirigidas de Cáncer de Pulmón en Español fue un evento en directo celebrado en julio de 2024 que reunió a los mejores oncólogos para debatir temas sobre el cáncer de pulmón para una audiencia de habla hispana.
La Dra. Estelamari Rodríguez presenta información básica sobre el NSCLC EGFR+ y analiza la importancia de las pruebas de biomarcadores en el cáncer de pulmón y ofrece una descripción general de las opciones de tratamiento para la enfermedad EGFR+. Para ver la playlist completa, de click aquí.
Oncologists discuss a variety of topics in lung cancer, including biomarker testing, immunotherapy, KRAS+ disease, and emerging therapies, among other topics.
In this latest update to the Lung Cancer Video Library, Oncologists discuss a variety of topics in lung cancer including biomarker testing, immunotherapy, KRAS+, emerging therapies, the changes that have occurred in treating NSCLC in the past few decades, Lung Cancer risk factors, and treatment
English: Oncologists speak on topics in lung cancer, including risk factors, targeted therapy options, and the importance of genetic testing.
Korean: 종양학자들은 위험 요인, 표적 치료 옵션, 유전자 검사의 중요성 등 폐암 관련 주제에 대해 강연합니다.
Korean: 종양학자들은 위험 요인, 표적 치료 옵션, 유전자 검사의 중요성 등 폐암 관련 주제에 대해 강연합니다.
In this video series, Dr. Chul Kim translates discussions on lung cancer in Korean. Videos include information on SCLC and NSCLC including statistics and risk factors. To watch the full playlist click here.
This series discusses recent advances in HPV-related cancers, including treatment options, vaccination recommendations, and patient perspectives.
In this video series, Dr. Paul Romesser discusses recent advances in HPV related cancers, including treatment options, vaccination recommendations and patient perspectives. To watch the full playlist click here.
In this Blood Cancer Video Library 2023 Program, Dr. Tycel Phillips (City of Hope) and Dr. Sridevi Rajeeve (Memorial Sloan Kettering) discuss topics in blood cancer, including AL Amyloidosis and Diffuse Large B-cell lymphoma.
Dr. Sridevi Rajeeve gives an overview of Amyloidosis types, signs, and symptoms, including AL Amyloidosis and treatment options. To watch the full playlist click here.
The 2023-2024 GRACE Patient Education Ambassadors discuss topics in a variety of cancers, from screening and treating prostate cancer to aiding in the cost of cancer treatment.
Drs. Matthew Kurian, Karan Jatwani, and Karine Tawagi discuss risk factors for developing prostate cancer, PSA test in prostate cancer screening, biopsies in prostate cancer, among other relevant information about prostate cancer. To watch the full playlist click here.
The 2023-2024 GRACE Patient Education Ambassadors discuss topics in a variety of cancers, from screening and treating prostate cancer to aiding in the cost of cancer treatment.
La Dra. Ivy Riano analiza las diversas opciones de tratamiento para pacientes con cáncer y analiza las diversas opciones de tratamiento para pacientes con cáncer. Para ver la lista completa de videos da click aquí.
The 2023-2024 GRACE Patient Education Ambassadors discuss topics in a variety of cancers, from screening and treating prostate cancer to aiding in the cost of cancer treatment.
Dr. Gladys Rodriguez and Hannah Manella, RD, discuss addressing nutritional concerns of patients who are undergoing cancer care.
Drs. Shetal Patel, Siddharth Sheth, and Jared Weiss discuss the most recent advances in head and neck cancer treatment.
Drs. Shetal Patel, Siddharth Sheth, and Jared Weiss discuss the most recent advances in head and neck cancer treatment, including curable and incurable head and neck cancers, thyroid cancers, and HPV positive and negative cancers.
A recorded live event where a team of top oncologists discusses emerging concepts and best practices in non-small cell lung cancer (NSCLC).
At our live event, Lung Cancer OncTalk 2023, Dr. Puneeth Iyengar discusses using radiation therapy in metastatic lung cancer, advances in Oligometastatic disease, (SBRT) for Oligoprogressive, The NRG-LU Trial, and future goals of metastatic NSCLC Treatment. To watch the complete playlist click here.
A recorded live event where a team of top oncologists discusses emerging concepts and best practices in non-small cell lung cancer (NSCLC).
At our live event, Lung Cancer OncTalk 2023, Lyudmila Bazhenova talks about Antibody Drug Conjugates, Toxicities in Antibody Drug Conjugate Treatment, and Bispecific Antibodies in Lung Cancer. To watch the complete playlist click here.
A recorded live event where a team of top oncologists discusses emerging concepts and best practices in non-small cell lung cancer (NSCLC).
At our live event, Lung Cancer OncTalk 2023, Dr. Yang, Das, and Dagogo-Jack discuss commonly used terms in treatment options for lung cancer, how oncologists determine the stage of lung cancer, and what that means for treatment, the importance of driver mutation in NSCLC treatment, the vast number